A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors
Clinical trial NCT06215846 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06215846
- Sponsor
- Beijing Bio-Targeting Therapeutics Technology Co., Ltd
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-07
- Primary completion
- 2026-05-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.